The inherent ability of the HIV-1 virus to mutate and evade immune responses poses an immense challenge to tackling HIV infections. A large European consortium is working on developing neutralising antibodies against the HIV virus envelope to prevent its entry into our cells.
Further information: cordis.europa.eu